There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Released in 2016, the Centers for Disease Control and Prevention (CDC) Guideline for
Prescribing Opioids for Chronic Pain has been met with both praise and criticism.
In this issue of the Journal, two commentaries address the guideline's strengths and
limitations. While the authors differ in their assessment of the guideline, they share
a common objective: safer opioid prescribing. Followed carefully, the CDC guideline
will facilitate this, but followed carelessly it has the potential to cause harm.
[1
]Divisions of General Internal Medicine and of Clinical Pharmacology and Toxicology,
Department of Medicine; University of Toronto; Toronto ON Canada